Results 191 to 200 of about 21,271 (292)

Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton   +3 more
wiley   +1 more source

Photostability of Cyanine Dyes and Its Correlation to Their Photothermal and Photodynamic Effects

open access: yesChemistry – A European Journal, EarlyView.
Photostability (PS) of dyes is a crucial parameter for performance in biological applications, yet often underrated. Here PS of several cyanines is investigated. The method is carefully evaluated and designed as a general and easy tool to compare PS of NIR dyes.
Clara Schäfer, Bo W. Laursen
wiley   +1 more source

Long‐Term Prognosis, Residual Recurrence Risk, and Postoperative Management After Pathological Complete Response in Rectal Cancer

open access: yesCancer Nexus, EarlyView.
This graphical abstract summarizes the post‐pCR clinical pathway in locally advanced rectal cancer. After neoadjuvant radiotherapy and systemic therapy followed by surgery, patients achieving pCR (ypT0N0) generally have durable disease control, although residual risks of local and distant recurrence remain. Risk assessment, guideline‐based surveillance,
Jia‐ang Wang   +3 more
wiley   +1 more source

Prediction of Acute Liver Injury Trajectory in Patients Following Acetaminophen Overdose: A Multibiomarker Machine Learning Proof‐of‐Concept Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Clinical translation of novel therapies can be hindered by heterogeneity‐driven sample size inflation in late‐stage trials. In acetaminophen‐induced liver injury (APAP DILI), many patients recover spontaneously, diluting investigational drug efficacy signals.
Chris Humphries   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy